PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
155 hedge funds and large institutions have $522M invested in Progenics Pharmaceuticals Inc in 2018 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 38 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
155
Holders Change
+3
Holders Change %
+1.97%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
19
Increased
57
Reduced
38
Closed
16
Calls
$14.3M
Puts
$5.48M
Net Calls
+$8.77M
Net Calls Change
+$7.32M
Top Buyers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
$21.3M |
| 2 |
BlackRock
New York
|
$91.6M |
| 3 |
Morgan Stanley
New York
|
$7.52M |
| 4 |
State Street
Boston,
Massachusetts
|
$33.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$34.7M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$56.2M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
$7.87M |
| 3 |
PA
Pinnacle Associates
New York
|
$14.4M |
| 4 |
JPMorgan Chase & Co
New York
|
$121K |
| 5 |
Fisher Asset Management
Camas,
Washington
|
$1.06M |
